PREPARATION FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

An preparation for treating systemic lupus erythematosus containing the following compound: wherein, when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharamacologica...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIYATA, TAKESHI, OGASAWARA, SADANORI, ISHII, TAKAYUKI, TAKAHAMA, KAZUO, KAI, HIROFUMI, KOMATSU, KENJI
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An preparation for treating systemic lupus erythematosus containing the following compound: wherein, when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharamacologically permittable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous.